SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950116-00-002540
Filing Date
2000-10-16
Accepted
2000-10-16 00:00:00
Documents
5
Period of Report
2000-10-04
Items
Item 5: Other events
Item 6: Resignations of registrant's directors

Document Format Files

Seq Description Document Type Size
1 FORM 8-K 0001.txt 8-K 10459
2 SECURITIES PURCHASE AGREEMENT 0002.txt EX-1 53597
3 EXHIBIT 2 0003.txt EX-2 56064
4 EXHIBIT 3 0004.txt EX-3 55769
5 WARRANT 0005.txt EX-4 47676
  Complete submission text file 0000950116-00-002540.txt   225586
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO M5J A1
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-25169 | Film No.: 740870
SIC: 2834 Pharmaceutical Preparations